USPTO serial 86530791
T2D
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KEATING, MICHAEL P
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with T2D?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maury M. Tepper, III
Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRALEIGH, NC 27609UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diabetes, obesity and metabolic diseases and disorders; drug delivery systems comprised of an implantable pump filled with pharmaceutical preparations for use in treating diabetes, obesity and metabolic diseases/disorders | ACTIVE | — |
| 010 | Drug delivery systems, namely an implantable pump; medical apparatus for the administration of pharmaceuticals in the nature of an implantable pump; medical apparatus for treatment of diabetes, obesity and metabolic diseases/disorders in the nature of an incretin memetic pump | ACTIVE | — |
| 041 | Development and dissemination of printed and electronic educational materials of others in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies and administration of pharmaceuticals; educational services, namely, conducting classes, seminars, conferences, workshops, field trips and programs in the fields of diabetes, obesity, metabolic diseases/disorders, and treatments relating thereto, drug delivery technologies and administration of pharmaceuticals, and distribution of educational material in connection therewith | ACTIVE | — |
| 042 | Research and development of pharmaceutical preparations, products and technology in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; medical and scientific research in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals; providing medical and scientific research information in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, administration of pharmaceuticals, pharmaceuticals, and clinical trials; scientific investigations for medical purposes; medical research; design and testing of new products, technologies and therapies in the fields of diabetes, obesity, metabolic diseases/disorders, drug delivery technologies, and administration of pharmaceuticals for others; providing information in the fields of clinical trials of pharmaceuticals | ACTIVE | — |
| 044 | Medical information services, namely, providing information on the topics of diabetes, obesity, and metabolic diseases/disorders and the diagnosis, treatment and management therapies relating thereto; providing information in the fields of medicine, pharmaceuticals, drug delivery technologies, and administration of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Intarcia Therapeutics, Inc.
- Other trademarks owned by Intarcia Therapeutics, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named T2D
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2018 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 8, 2018 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 5, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 5, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 2, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 28, 2018 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Feb 28, 2018 | EXT4 | SOU EXTENSION 4 FILED | — |
| Feb 28, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 18, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 16, 2017 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 16, 2017 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 16, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 2, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 2, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 2, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 31, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 31, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 31, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 26, 2016 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 24, 2016 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 24, 2016 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 24, 2016 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 1, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 5, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 16, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 19, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 18, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 15, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 26, 2015 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 25, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 13, 2015 | NWAP | NEW APPLICATION ENTERED | — |